Below are the most recent publications written about "Nitro Compounds" by people in Profiles.
-
Zhu HT, Luo J, Peng Y, Cheng XF, Wu SZ, Zhao YD, Chang L, Sun ZJ, Dong DL. Nitazoxanide protects against experimental ulcerative colitis through improving intestinal barrier and inhibiting inflammation. Chem Biol Interact. 2024 May 25; 395:111013.
-
Sviatenko LK, Gorb L, Leszczynski J. NTO Degradation by Nitroreductase: A DFT Study. J Phys Chem B. 2022 08 18; 126(32):5991-6006.
-
Gorb L, Ilchenko M, Leszczynski J. Decomposition of 2,4,6-trinitrotoluene (TNT) and 5-nitro-2,4-dihydro-3H-1,2,4-triazol-3-one (NTO) by Fe13O13 nanoparticle: density functional theory study. Environ Sci Pollut Res Int. 2022 Sep; 29(45):68522-68531.
-
Santos CC, Zhang H, Batista MM, de Oliveira GM, Demarque KC, da Silva NL, Moreira OC, Ogungbe IV, Soeiro MNC. Phenotypic investigation of 4-nitrophenylacetyl- and 4-nitro-1H-imidazoyl-based compounds as antileishmanial agents. Parasitology. 2022 04; 149(4):490-495.
-
Zhao Y, Chang Z, Zhao G, Lu H, Xiong W, Liang W, Wang H, Villacorta L, Garcia-Barrio MT, Zhu T, Guo Y, Fan Y, Chang L, Schopfer FJ, Freeman BA, Zhang J, Chen YE. Suppression of Vascular Macrophage Activation by Nitro-Oleic Acid and its Implication for Abdominal Aortic Aneurysm Therapy. Cardiovasc Drugs Ther. 2021 10; 35(5):939-951.
-
Perelygina L, Buchbinder D, Dorsey MJ, Eloit M, Hauck F, Hautala T, Moshous D, Uriarte I, Deripapa E, Icenogle J, Sullivan KE. Outcomes for Nitazoxanide Treatment in a Case Series of Patients with Primary Immunodeficiencies and Rubella Virus-Associated Granuloma. J Clin Immunol. 2019 01; 39(1):112-117.
-
Hautala TJ, Perelygina L, Vuorinen T, Hautala NM, H?gg PM, Bode MK, Rusanen HT, Renko MH, Glumoff V, Schwab N, Schneider-Hohendorf T, Murk JL, Sullivan KE, Sepp?nen MRJ. Nitazoxanide May Modify the Course of Progressive Multifocal Leukoencephalopathy. J Clin Immunol. 2018 01; 38(1):4-6.
-
Perelygina L, Hautala T, Sepp?nen M, Adebayo A, Sullivan KE, Icenogle J. Inhibition of rubella virus replication by the broad-spectrum drug nitazoxanide in cell culture and in a patient with a primary immune deficiency. Antiviral Res. 2017 Nov; 147:58-66.
-
Farley C, Aggarwal A, Singh S, Dolor A, To P, Falber A, Crossley M, Drain CM. A Structural Model of Nitro-Porphyrin Dyes Based on Spectroscopy and Density Functional Theory. J Comput Chem. 2018 07 05; 39(18):1129-1142.
-
Gooch A, Sizochenko N, Sviatenko L, Gorb L, Leszczynski J. A quantum chemical based toxicity study of estimated reduction potential and hydrophobicity in series of nitroaromatic compounds. SAR QSAR Environ Res. 2017 Feb; 28(2):133-150.